Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

FRA:S1R Statistics

Total Valuation

FRA:S1R has a market cap or net worth of EUR 7.29 billion. The enterprise value is 10.72 billion.

Market Cap	7.29B
Enterprise Value	10.72B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	Jul 16, 2025

Share Statistics

Current Share Class	919.07M
Shares Outstanding	n/a
Shares Change (YoY)	-0.93%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	15.62%
Float	1.58B

Valuation Ratios

The trailing PE ratio is 10.78 and the forward PE ratio is 12.26.

PE Ratio	10.78
Forward PE	12.26
PS Ratio	0.22
PB Ratio	0.68
P/TBV Ratio	1.12
P/FCF Ratio	18.93
P/OCF Ratio	11.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.66, with an EV/FCF ratio of 27.83.

EV / Earnings	15.86
EV / Sales	0.31
EV / EBITDA	8.66
EV / EBIT	11.12
EV / FCF	27.83

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.66.

Current Ratio	1.32
Quick Ratio	1.00
Debt / Equity	0.66
Debt / EBITDA	5.79
Debt / FCF	18.32
Interest Coverage	4.52

Financial Efficiency

Return on equity (ROE) is 7.91% and return on invested capital (ROIC) is 3.44%.

Return on Equity (ROE)	7.91%
Return on Assets (ROA)	2.15%
Return on Invested Capital (ROIC)	3.44%
Return on Capital Employed (ROCE)	8.10%
Revenue Per Employee	680,222
Profits Per Employee	13,681
Employee Count	49,402
Asset Turnover	1.22
Inventory Turnover	6.33

Taxes

In the past 12 months, FRA:S1R has paid 340.10 million in taxes.

Income Tax	340.10M
Effective Tax Rate	29.37%

Stock Price Statistics

The stock price has decreased by -16.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.88%
50-Day Moving Average	1.30
200-Day Moving Average	1.31
Relative Strength Index (RSI)	45.01
Average Volume (20 Days)	25

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:S1R had revenue of EUR 33.60 billion and earned 675.86 million in profits. Earnings per share was 0.18.

Revenue	33.60B
Gross Profit	3.55B
Operating Income	948.22M
Pretax Income	1.16B
Net Income	675.86M
EBITDA	1.13B
EBIT	948.22M
Earnings Per Share (EPS)	0.18

Balance Sheet

The company has 5.33 billion in cash and 7.05 billion in debt, giving a net cash position of -1.72 billion.

Cash & Cash Equivalents	5.33B
Total Debt	7.05B
Net Cash	-1.72B
Net Cash Per Share	n/a
Equity (Book Value)	10.73B
Book Value Per Share	2.45
Working Capital	5.38B

Cash Flow

In the last 12 months, operating cash flow was 645.77 million and capital expenditures -260.72 million, giving a free cash flow of 385.05 million.

Operating Cash Flow	645.77M
Capital Expenditures	-260.72M
Free Cash Flow	385.05M
FCF Per Share	n/a

Margins

Gross margin is 10.57%, with operating and profit margins of 2.82% and 2.01%.

Gross Margin	10.57%
Operating Margin	2.82%
Pretax Margin	3.45%
Profit Margin	2.01%
EBITDA Margin	3.37%
EBIT Margin	2.82%
FCF Margin	1.15%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.72%.

Dividend Per Share	0.03
Dividend Yield	2.72%
Dividend Growth (YoY)	-43.64%
Years of Dividend Growth	n/a
Payout Ratio	50.60%
Buyback Yield	0.93%
Shareholder Yield	3.64%
Earnings Yield	9.27%
FCF Yield	5.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:S1R has an Altman Z-Score of 2.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	4